Harnessing nanoparticles for immunomodulation and vaccines
The first successful use of nanoparticles (NPs) for vaccination was reported almost 40 years ago with a virus-like particle-based vaccine against Hepatitis B. Since then, the term NP has been expanded to accommodate a large number of novel nano-sized particles engineered from a range of materials. T...
मुख्य लेखकों: | Gomes, AC, Mohsen, M, Bachmann, M |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
MDPI
2017
|
समान संसाधन
-
Harnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation
द्वारा: Karthikeyan Elumalai, और अन्य
प्रकाशित: (2025-12-01) -
Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches
द्वारा: Ning Zhang, और अन्य
प्रकाशित: (2024-08-01) -
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake
द्वारा: Madison L. Seefeld, और अन्य
प्रकाशित: (2024-09-01) -
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
द्वारा: Jeffrey Schlom, और अन्य
प्रकाशित: (2020-05-01) -
Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulation
द्वारा: Vishali Moond, और अन्य
प्रकाशित: (2024-08-01)